Company profile
GlyProVac company profile
GlyProVac is pursuing the development of a glycoprotein based vaccine against Enterotoxigenic Escherichia coli (ETEC).
Business identity
- Website
- http://glyprovac.com/
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0+
- Founded
- 2018-01-01, Year
Headquarters
- Headquarters
- Odense, South Denmark, Denmark
- Postal code
- 5220
- Country code
- DK
- Continent
- Europe